These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 16009588)
1. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Balanag VM; Yunus F; Yang PC; Jorup C Pulm Pharmacol Ther; 2006; 19(2):139-47. PubMed ID: 16009588 [TBL] [Abstract][Full Text] [Related]
2. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. Berger WE; Noonan MJ J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study. Morice AH; Peterson S; Beckman O; Kukova Z Pulm Pharmacol Ther; 2008; 21(1):152-9. PubMed ID: 17376722 [TBL] [Abstract][Full Text] [Related]
6. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Corren J; Korenblat PE; Miller CJ; O'Brien CD; Mezzanotte WS Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. Jenkins C; Kolarikova R; Kuna P; Caillaud D; Sanchis J; Popp W; Pettersson E Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085 [TBL] [Abstract][Full Text] [Related]
8. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478 [TBL] [Abstract][Full Text] [Related]
9. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018 [TBL] [Abstract][Full Text] [Related]
10. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230 [TBL] [Abstract][Full Text] [Related]
11. Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma. Ankerst J; Persson G; Weibull E Pulm Pharmacol Ther; 2003; 16(3):147-51. PubMed ID: 12749830 [TBL] [Abstract][Full Text] [Related]
12. Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. Bateman ED; Fairall L; Lombardi DM; English R Respir Res; 2006 Jan; 7(1):13. PubMed ID: 16433920 [TBL] [Abstract][Full Text] [Related]
13. Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma. Morice AH; Hochmuth L; Ekelund J; Thorén A; Puterman AS Pulm Pharmacol Ther; 2008; 21(1):32-9. PubMed ID: 17118686 [TBL] [Abstract][Full Text] [Related]
14. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575 [TBL] [Abstract][Full Text] [Related]
15. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma. O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing. Kerwin EM; Oppenheimer JJ; LaForce C; Parasuraman B; Miller CJ; O'Dowd L; Goldman M Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942 [TBL] [Abstract][Full Text] [Related]
18. Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. Pohunek P; Kuna P; Jorup C; De Boeck K Pediatr Allergy Immunol; 2006 Sep; 17(6):458-65. PubMed ID: 16925692 [TBL] [Abstract][Full Text] [Related]
19. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety. Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189 [TBL] [Abstract][Full Text] [Related]
20. Budesonide/formoterol (Symbicort) is well tolerated and effective in patients with moderate persistent asthma. Rosenhall L; Heinig JH; Lindqvist A; Leegaard J; Ståhl E; Bergqvist PB Int J Clin Pract; 2002; 56(6):427-33. PubMed ID: 12166540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]